Search

Your search keyword '"Flevari A"' showing total 621 results

Search Constraints

Start Over You searched for: Author "Flevari A" Remove constraint Author: "Flevari A"
621 results on '"Flevari A"'

Search Results

2. Treatment of invasive candidiasis in the elderly: a review

3. Performance of Different Risk Scores for the Detection of Atrial Fibrillation Among Patients With Cryptogenic Stroke

4. Pulmonary Hypertension in Sickle Cell Disease: Novel Findings of Gene Polymorphisms Related to Pathophysiology

5. Peripheral Neuropathy in Patients with Hepatitis C Infection—Reversibility after HCV Eradication: A Single Center Study

6. High-Oxygen-Affinity Hemoglobins—Case Series and Review of the Literature

8. Present criteria for prophylactic ICD implantation: Insights from the EU-CERT-ICD (Comparative Effectiveness Research to Assess the Use of Primary ProphylacTic Implantable Cardioverter Defibrillators in EUrope) project

12. Gaucher-like Cells in Thalassemia Intermedia: Is It a Challenge?

13. Luspatercept for the treatment of anaemia in non-transfusion-dependent β-thalassaemia (BEYOND): a phase 2, randomised, double-blind, multicentre, placebo-controlled trial

16. Nocturnal respiratory rate predicts ICD benefit: A prospective, controlled, multicentre cohort study

18. Pulmonary Hypertension in Sickle Cell Disease: Novel Findings of Gene Polymorphisms Related to Pathophysiology.

19. Noninvasive risk factors for the prediction of inducibility on programmed ventricular stimulation in post‐myocardial infarction patients with an ejection fraction ≥40% at risk for sudden cardiac arrest: Insights from the PRESERVE‐EF study

23. Case Report of Myelodysplastic Syndrome in a Sickle-Cell Disease Patient Treated with Hydroxyurea and Literature Review

24. S283: ERN-EUROBLOODNET EUROPEAN REGISTRY OF PATIENTS AFFECTED BY RED BLOOD CELL DISORDERS AND COVID-19

26. Differential multivariable risk prediction of appropriate shock versus competing mortality - A prospective cohort study to estimate benefits from ICD therapy

28. Data on differential multivariable risk prediction of appropriate shock vs. competing mortality

29. The haemostatic profile in critically ill COVID-19 patients receiving therapeutic anticoagulant therapy: An observational study

31. Case Report of Myelodysplastic Syndrome in a Sickle-Cell Disease Patient Treated with Hydroxyurea and Literature Review

32. The Clinical Significance of the Glomerular Biomarker Soluble Urokinase-Type Plasminogen Activator Receptor (suPAR) in Renal Function of Caucasian Patients with Compound Heterozygosity for Hb S and β-Thalassemia

33. Luspatercept for the treatment of anaemia in non-transfusion-dependent β-thalassaemia (BEYOND): a phase 2, randomised, double-blind, multicentre, placebo-controlled trial

34. Prevalence, associated factors and outcomes of pressure injuries in adult intensive care unit patients: the DecubICUs study

35. Clinical effectiveness of primary prevention implantable cardioverter-defibrillators: results of the EU-CERT-ICD controlled multicentre cohort study

36. Ferritin levels in critically ill patients with COVID-19: A marker of outcome?

37. The Clinical Significance of the Glomerular Biomarker Soluble Urokinase-Type Plasminogen Activator Receptor (suPAR) in Renal Function of Caucasian Patients with Compound Heterozygosity for Hb S and β-Thalassemia

38. Invasive Fungal Infections in the ICU: How to Approach, How to Treat

39. Siblings with coronavirus disease 2019 infection and opposite outcome—the hemodialysis’s better outcome paradox: Two case reports

40. Arrhythmic risk stratification in nonischemic dilated cardiomyopathy: The ReCONSIDER study design – A two-step, multifactorial, electrophysiology-inclusive approach

41. S283: ERN-EUROBLOODNET EUROPEAN REGISTRY OF PATIENTS AFFECTED BY RED BLOOD CELL DISORDERS AND COVID-19

42. Luspatercept for the treatment of anaemia in non-transfusion-dependent β-thalassaemia (BEYOND): a phase 2, randomised, double-blind, multicentre, placebo-controlled trial

43. Intrapulmonary pharmacokinetics of high doses of tigecycline in patients with ventilator-associated pneumonia

48. Implantable Cardiac Monitoring in the Secondary Prevention of Cryptogenic Stroke

Catalog

Books, media, physical & digital resources